Aspirin for pre-eclampsia: compelling data on benefit and risk.
Roberts
James M
JM
Department of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh, Magee-Womens Research Institute, Pittsburgh, PA 15213, USA; Department of Epidemiology, University of Pittsburgh, Magee-Womens Research Institute, Pittsburgh, PA 15213, USA. Electronic address: rsijmr@mwri.magee.edu.
Catov
Janet M
JM
Department of Epidemiology, University of Pittsburgh, Magee-Womens Research Institute, Pittsburgh, PA 15213, USA.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D011225:Pre-Eclampsia / Q000517:prevention & control*; D011247:Pregnancy; D011256:Pregnancy Outcome; D018570:Risk Assessment
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001241:Aspirin